CERUS CORP Cash and Restricted Cash
CERUS CORP (CERS) had Cash and Restricted Cash of $18.61 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-30
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18.61M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $28.48M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $20.60M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $16.81M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $18.61M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $28.48M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $20.60M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $16.81M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $17.13M 10-Q · filed 2026-07-30 |
| 2025-03-31 | $20.59M 10-Q · filed 2026-04-30 |
| 2024-12-31 | $21.36M 10-Q · filed 2026-07-30 |
| 2024-09-30 | $23.21M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $14.11M 10-Q · filed 2025-08-05 |
| 2024-03-31 | $22.23M 10-Q · filed 2025-05-01 |
| 2023-12-31 | $13.36M 10-K · filed 2026-03-02 |
| 2023-09-30 | $19.16M 10-Q · filed 2024-10-31 |
| 2023-06-30 | $22.43M 10-Q · filed 2024-08-01 |
| 2023-03-31 | $29.39M 10-Q · filed 2024-05-02 |
| 2022-12-31 | $37.36M 10-K · filed 2026-03-02 |
| 2022-09-30 | $30.87M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $34.32M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $40.38M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $51.04M 10-K · filed 2025-02-26 |
| 2021-09-30 | $80.74M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $61.29M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $59.81M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $38.90M 10-K · filed 2024-03-05 |
| 2020-09-30 | $31.47M 10-Q · filed 2021-11-02 |
| 2020-06-30 | $37.36M 10-Q · filed 2021-08-03 |
| 2020-03-31 | $36.12M 10-Q · filed 2021-05-04 |
| 2019-12-31 | $37.42M 10-K · filed 2023-03-01 |
| 2019-09-30 | $27.10M 10-Q · filed 2020-10-29 |
| 2019-06-30 | $26.22M 10-Q · filed 2020-08-04 |
| 2019-03-31 | $31.73M 10-Q · filed 2020-05-05 |
| 2018-12-31 | $31.59M 10-K · filed 2022-02-22 |
| 2018-09-30 | $25.06M 10-Q · filed 2019-10-30 |
| 2018-06-30 | $17.03M 10-Q · filed 2019-08-01 |
| 2018-03-31 | $17.69M 10-Q · filed 2019-05-07 |
| 2017-12-31 | $13.93M 10-K · filed 2021-02-25 |
| 2017-09-30 | $17.24M 10-Q · filed 2018-11-01 |
| 2017-06-30 | $20.53M 10-Q · filed 2018-08-02 |
| 2017-03-31 | $11.19M 10-Q · filed 2018-05-08 |
| 2016-12-31 | $22.74M 10-K · filed 2020-02-21 |
| 2015-12-31 | $71.63M 10-K · filed 2019-02-27 |
| 2014-12-31 | $23.29M 10-K · filed 2018-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |